TY - JOUR T1 - Microwave ablation <em>vs</em>. surgical resection for treatment naïve hepatocellular carcinoma within the Milan criteria: a follow-up of at least 5 years JF - Cancer Biology &amp; Medicine JO - Cancer Biology &amp; Medicine SP - 1078 LP - 1088 DO - 10.20892/j.issn.2095-3941.2020.0625 VL - 19 IS - 7 AU - Jianping Dou AU - Zhigang Cheng AU - Zhiyu Han AU - Fangyi Liu AU - Zhen Wang AU - Xiaoling Yu AU - Jie Yu AU - Ping Liang Y1 - 2022/07/15 UR - http://www.cancerbiomed.org/content/19/7/1078.abstract N2 - Objective: Thermal ablation poses challenges in the surgical resection (SR) of small hepatocellular carcinoma (HCC), and its therapeutic outcomes for larger lesions remain debated.Methods: This retrospective study evaluated 729 patients with HCC meeting the Milan criteria, who were treated with curative SR or microwave ablation (MWA) between 2008 and 2014. Overall survival (OS), cancer-specific survival (CSS), disease-free survival (DFS), and local tumor progression (LTP) were compared after propensity score matching (PSM). Co-variates associated with OS, CSS, LTP, and DFS were identified. The risk of death and tumor progression were compared.Results: During the median follow-up of 78.6 months, 253 patients were included in each group after PSM. For tumors ≤ 3.0 cm and 3.1–4.0 cm, MWA achieved comparable results in terms of OS, CSS, DFS, and LTP. For tumors 4.1–5.0 cm, MWA had lower OS, CSS, and DFS rates (all P &lt; 0.05) than SR. Higher LTP rates were observed in the MWA group for tumors 4.1–5.0 cm, although the difference was not significant (P = 0.18). Complication rates (P = 0.41) were similar, but MWA led to less estimated blood loss (P &lt; 0.01) and shorter postoperative hospitalization times (P &lt; 0.01).Conclusions: MWA achieved comparable long-term oncologic outcomes with SR for ≤ 4 cm HCC, with lower complication rates and faster recovery. ER -